SPYRE THERAPEUTICS INC (SYRE) Stock Balance Sheet
NASDAQ:SYRE - Nasdaq - US00773J2024 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 89.42M | 188.89M | 34.90M | 15.10M | 90.10M | |||
| Marketable Securities | 513.66M | 150.38M | 20.80M | 78.00M | 56.20M | |||
| Receivables | N/A | 0.00 | 400.00K | 800.00K | N/A | |||
| Other Current Assets | 5.39M | 2.25M | 6.20M | 4.90M | 3.50M | |||
| Total Current Assets | 608.47M | 341.53M | 62.30M | 98.90M | 149.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 0.00 | 7.20M | 9.20M | 9.90M | |||
| Other Non-Current Assets | 10.00K | 331.00K | 1.60M | 1.90M | 1.90M | |||
| Total Non-Current Assets | 10.00K | 331.00K | 8.80M | 11.00M | 11.80M | |||
| TOTAL ASSETS | 608.48M | 341.86M | 71.10M | 109.90M | 161.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 400.00K | 0.00 | |||
| Accrued Expenses | 27.71M | 13.11M | 13.40M | 14.00M | 14.20M | |||
| Accounts Payable | 1.27M | 17.48M | 700.00K | 3.30M | 2.30M | |||
| Other Current Liabilities | 25.08M | 1.39M | 500.00K | 2.40M | N/A | |||
| Total Current Liabilities | 54.06M | 31.98M | 14.70M | 20.10M | 16.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 36.62M | 41.31M | 6.20M | 5.80M | 5.30M | |||
| Total Non-Current Liabilities | 36.62M | 41.31M | 6.10M | 5.90M | 5.40M | |||
| TOTAL LIABILITIES | 90.68M | 73.29M | 20.80M | 26.00M | 21.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -972.43M | -764.41M | -425.60M | -341.80M | -276.00M | |||
| Additional Paid In Capital | 1.33B | 763.19M | 476.00M | 425.80M | 415.80M | |||
| Common Shares | 155.83M | 269.49M | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 180.00K | 302.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 60.26M | 36.06M | 2.60M | 2.00M | 1.90M | |||
| Tangible Book Value per Share | 6.01 | -0.03 | 19.35 | 41.95 | 73.58 | |||
| Total Shareholders' Equity | 517.80M | 268.57M | 50.30M | 83.90M | 139.80M | |||
| TOTAL LIABILITIES AND EQUITY | 608.48M | 341.86M | 71.10M | 109.90M | 161.60M | |||
| Statistics | ||||||||
| Current Ratio | 11.26 | 10.68 | 4.24 | 4.92 | 9.13 | |||
| Return On Assets (ROA) | -34.19% | -99.10% | -117.89% | -59.87% | -50.06% | |||
| Return On Equity (ROE) | -40.17% | -126.15% | -166.64% | -78.43% | -57.86% | |||
All data in USD , ROIC based on taxRate of 0.21